- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Millennium Pharmaceuticals, Inc.
Total 4987 results
-
NYU Langone HealthMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Oncology Specialists, S.C.Millennium Pharmaceuticals, Inc.TerminatedLymphoma, B-Cell | Lymphoma, Non-HodgkinUnited States
-
Samsung Medical CenterMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin LymphomaKorea, Republic of
-
University of ArkansasMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedFollicular Lymphoma | Burkitt Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Imperial College LondonMillennium Pharmaceuticals, Inc.CompletedLung Diseases, ObstructiveUnited Kingdom
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.CompletedHematological MalignancyUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Boston Medical CenterMillennium Pharmaceuticals, Inc.Completed
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.CompletedAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | B-cell Adult Acute Lymphoblastic Leukemia | T-cell Adult Acute Lymphoblastic LeukemiaUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.CompletedAsymptomatic Multiple MyelomaUnited States
-
University of PittsburghMillennium Pharmaceuticals, Inc.CompletedAdenoid Cystic CarcinomaUnited States
-
University of CincinnatiMillennium Pharmaceuticals, Inc.Completed
-
Georgetown UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
Baylor Research InstituteMillennium Pharmaceuticals, Inc.UnknownChronic Graft-versus-host DiseaseUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMantle Cell LymphomaChina, Belgium, Thailand, United States, Spain, Canada, Colombia, Italy, Morocco, Brazil, Turkey, Chile, Malaysia, Israel, Portugal, Singapore, Russian Federation, Philippines, Tunisia, Austria, Czechia, Germany, Hungary, India, Poland, R... and more
-
University of LeipzigMillennium Pharmaceuticals, Inc.CompletedMyelodysplastic Syndromes | Minimal Residual Disease | Acute Myeloid Leukemia in RemissionGermany
-
US Oncology ResearchMillennium Pharmaceuticals, Inc.Active, not recruitingBreast Cancer | Breast Tumors | Breast Carcinoma | Malignant Neoplasm of BreastUnited States
-
University of WashingtonMillennium Pharmaceuticals, Inc.Active, not recruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Small Lymphocytic Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal...United States
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
University of UtahMillennium Pharmaceuticals, Inc.TerminatedCancer | Multiple Myeloma | MyelomaUnited States
-
Emory UniversityPfizer; Millennium Pharmaceuticals, Inc.Completed
-
Boston VA Research Institute, Inc.Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Emory UniversityMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.CompletedProtocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple MyelomaMultiple MyelomaUnited States, Canada
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research...Completed
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.Completed
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.Completed
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Massachusetts Institute of TechnologyMillennium Pharmaceuticals, Inc.CompletedPatient Reported Outcome Measures | ComplianceUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma, B-CellUnited States
-
University of RochesterMillennium Pharmaceuticals, Inc.; CephalonCompletedNon-Hodgkin's LymphomaUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingSolid Tumor | Urethral CancerUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLung Cancer | MesotheliomaUnited States
-
Antonio FojoMillennium Pharmaceuticals, Inc.WithdrawnMedullary Thyroid Cancer
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphomaUnited States
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.CompletedPost Menopausal, Hormone Receptor Positive Breast CancerUnited States
-
Fox Chase Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.WithdrawnMalignant Neoplasms of Female Genital Organs | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Digestive Organs | Malignant Neoplasms of Male Genital Organs
-
Mark StegallMillennium Pharmaceuticals, Inc.TerminatedDisorder of Transplanted KidneyUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma | Hodgkin LymphomaUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; Aventis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedThyroid Cancer | Differentiated Thyroid Cancer | Anaplastic Thyroid CancerUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAdvanced CancersUnited States